139 related articles for article (PubMed ID: 38182226)
21. HIV-associated multicentric Castleman disease: a report of 19 cases at an oncology institution.
Volkow-Fernández P; Lome-Maldonado C; Quintero-Buenrostro H; Islas-Muñoz B; Cornejo-Juárez P
Int J STD AIDS; 2020 Mar; 31(4):318-325. PubMed ID: 32089093
[No Abstract] [Full Text] [Related]
22. [Castleman disease].
Meignin V; Calvani J; Oksenhendler E
Ann Pathol; 2023 Jan; 43(1):13-24. PubMed ID: 36192235
[TBL] [Abstract][Full Text] [Related]
23. Multicentric Castleman Disease and Concurrent Hematological Disorders: The Occurrence of Plasmacytoma and the Hypotheses Arising from Literature Review.
Duminuco A; Romano A; Sabattini E; Villari L; Del Fabro V; Elia F; Palumbo GA; Di Raimondo F; Conticello C
Acta Haematol; 2023; 146(4):331-337. PubMed ID: 37068478
[TBL] [Abstract][Full Text] [Related]
24. Reply to Zhou et al. 'A novel approach for characterization of KSHV-associated multicentric Castleman disease from effusions'.
Vanjak A; Garzaro M; Knapp S; Silvestrini MA; Martin de Fremont G; Bertinchamp R; Calvani J; Meignin V; Dossier A; Galicier L; Oksenhendler E; Boutboul D
Br J Haematol; 2023 Apr; 201(2):357-359. PubMed ID: 36786160
[No Abstract] [Full Text] [Related]
25. Portal hypertension and refractory ascites associated with multicentric Castleman's disease.
Abarca M; Andrade RJ; García-Arjona A; Escolar JL; Blanes A; García-Hirschfeld JM; González-Santos P
Dig Dis Sci; 2000 Apr; 45(4):697-702. PubMed ID: 10759237
[No Abstract] [Full Text] [Related]
26. Two cases of idiopathic multicentric Castleman disease with nephrotic syndrome treated with tocilizumab.
Furutera N; Fukunaga N; Okita J; Suzuki T; Suenaga Y; Oyama Y; Aoki K; Fukuda A; Nakata T; Uesugi N; Daa T; Hisano S; Shibata H
CEN Case Rep; 2021 Feb; 10(1):35-41. PubMed ID: 32715375
[TBL] [Abstract][Full Text] [Related]
27. Multicentric Castleman disease of hyaline vascular variant presenting with unusual systemic manifestations: a case report.
Basnayake BMDB; Wazil AWM; Kannangara T; Ratnatunga NVI; Hewamana S; Ameer AM
J Med Case Rep; 2017 May; 11(1):135. PubMed ID: 28501028
[TBL] [Abstract][Full Text] [Related]
28. [Abdominal pain and weight loss in a 64 year-old woman].
Outh R; Fayard D; Aumaître O; André M; Cohen-Aubart F; Lhote R
Rev Med Interne; 2019 Feb; 40(2):126-128. PubMed ID: 30057211
[No Abstract] [Full Text] [Related]
29. Aseptic Meningitis-retention Syndrome Associated with Tocilizumab in a Patient with Idiopathic Multicentric Castleman Disease.
Arakawa A; Iizuka M; Matsuda S; Matsubara E; Yamazaki H; Yoshikawa N; Tanaka H; Yoshizawa T
Intern Med; 2021 Dec; 60(24):3995-3998. PubMed ID: 34219105
[TBL] [Abstract][Full Text] [Related]
30. A rare case of idiopathic multicentric Castleman disease in a patient with long-standing systemic autoimmunity.
Saleh M; Hallbeck M; Sjöwall C
Scand J Rheumatol; 2022 Mar; 51(2):161-163. PubMed ID: 34473003
[No Abstract] [Full Text] [Related]
31. Idiopathic Multicentric Castleman Disease with Autoimmune Hemolytic Anemia and Production of Anti-drug Antibody against Tocilizumab.
Tabata S; Higuchi T; Tatsukawa S; Narimatsu K; Takeo H; Matsukuma S; Ito T
Intern Med; 2019 Nov; 58(22):3313-3318. PubMed ID: 31292389
[TBL] [Abstract][Full Text] [Related]
32. [Anatomo-clinical conference. Hôpital de la Pitié-Salpêtrière. Case No 1--1997. Peripheral neuropathy and cervical adenopathy in a 58-year-old diabetic patient].
Papo T; Amoura I; Boddaert A
Ann Med Interne (Paris); 1997; 148(5):390-7. PubMed ID: 9538415
[No Abstract] [Full Text] [Related]
33. Membranous Nephropathy Associated With Multicentric Castleman Disease-Efficacy of Interleukin 6 Antibody for Nephrotic Syndrome.
Horino T; Kashio T; Inotani S; Ishihara M; Ichii O
J Clin Rheumatol; 2022 Jan; 28(1):e1-e2. PubMed ID: 34897198
[No Abstract] [Full Text] [Related]
34. Multicentric plasma cell variant Castleman's disease mimicking intrapulmonary malignancy.
Buckley J; Shaw PJ; Cartledge JD; Miller RF
Sex Transm Infect; 2002 Aug; 78(4):304-5. PubMed ID: 12181475
[No Abstract] [Full Text] [Related]
35. Multicentric Castlemans disease. Symptoms, diagnostics and therapy.
Adam Z; Řehák Z; Adamová Z; Koukalová R; Pour L; Krejčí M; Boichuk I; Sandecká V; Krejčí M; Štork M; Ševčíková S; Král Z
Vnitr Lek; 2022; 68(1):41-53. PubMed ID: 35459346
[TBL] [Abstract][Full Text] [Related]
36. Castleman disease and TAFRO syndrome.
Masaki Y; Arita K; Sakai T; Takai K; Aoki S; Kawabata H
Ann Hematol; 2022 Mar; 101(3):485-490. PubMed ID: 35044513
[TBL] [Abstract][Full Text] [Related]
37. Primary effusion lymphoma metachronous to multicentric Castleman disease in an immunocompetent patient.
Parente P; Zanelli M; Zizzo M; Covelli C; Carosi I; Ascani S; Graziano P
Pathol Res Pract; 2020 Jul; 216(7):153024. PubMed ID: 32534717
[TBL] [Abstract][Full Text] [Related]
38. Multicentric Castleman disease with secondary AA renal amyloidosis, nephrotic syndrome and chronic renal failure, remission after high-dose melphalan and autologous stem cell transplantation.
Ogita M; Hoshino J; Sogawa Y; Sawa N; Katori H; Takemoto F; Ubara Y; Hara S; Miyakoshi S; Takaichi K
Clin Nephrol; 2007 Sep; 68(3):171-6. PubMed ID: 17915620
[TBL] [Abstract][Full Text] [Related]
39. Peripheral neuropathy associated with Castleman's disease.
Donaghy M; Hall P; Gawler J; Gregson NA; Leibowitz S; Jitpimolmard S; King RH; Thomas PK
J Neurol Sci; 1989 Feb; 89(2-3):253-67. PubMed ID: 2538575
[TBL] [Abstract][Full Text] [Related]
40. Reactive lymphadenopathy with concurrent idiopathic plasma cell variant Castleman disease, amyloid deposition and non-caseating granulomas.
El Achi H; Glass WF; Wang W; Medeiros LJ; Hu Z
Pathology; 2019 Dec; 51(7):762-764. PubMed ID: 31662201
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
